ClinicalTrials.Veeva

Menu

Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases (AHS)

H

Healthsystem Plus

Status

Unknown

Conditions

High Blood Pressure
Cardiovascular Diseases

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00629954
HIFA-001

Details and patient eligibility

About

This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

Full description

Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa .

Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.

Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Some history of cardiovascular disease,PLWHA
  • Patients have to agree to participate by signing a consent
  • 18 years and older

Exclusion criteria

  • Stroke

Trial design

10,000 participants in 1 patient group

I

Trial contacts and locations

5

Loading...

Central trial contact

Uchenna N Onyeachom

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems